Cellectar biosciences, inc. (CLRB)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
COSTS AND EXPENSES:
Research and development

2,616

2,174

2,703

1,809

2,308

992

1,995

1,723

2,124

3,099

2,333

2,175

1,856

1,440

1,305

965

1,039

964

1,167

1,382

1,643

1,398

1,470

1,380

1,715

1,553

2,066

1,648

1,590

1,226

1,253

1,314

1,328

1,159

1,005

961

471

500

963

General and administrative

1,342

1,210

1,260

1,390

1,321

1,216

1,091

1,181

1,329

988

1,150

1,040

955

1,208

1,162

1,367

961

799

834

817

943

854

802

959

1,087

1,405

843

1,073

1,121

936

800

896

997

858

905

796

131

106

567

Restructuring costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

89

90

-

0

0

204

16

1,096

0

0

0

-

-

-

-

-

-

-

-

-

-

Merger costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

495

250

-

-

Total costs and expenses

3,958

3,384

3,963

3,200

3,629

3,884

3,087

2,904

3,453

4,088

3,483

3,216

2,812

2,648

2,467

2,332

2,000

1,786

2,092

2,291

2,587

2,253

2,273

2,545

2,819

4,056

2,910

2,722

2,712

2,163

2,054

2,211

2,325

2,018

1,911

2,254

853

607

1,530

LOSS FROM OPERATIONS

-3,958

-3,384

-3,963

-3,200

-3,629

-3,884

-3,087

-2,904

-3,453

-4,088

-3,483

-3,216

-2,812

-2,648

-2,467

-2,332

-2,000

-1,786

-2,092

-2,291

-2,587

-2,253

-2,273

-2,545

-2,819

-4,056

-2,910

-2,722

-2,712

-2,163

-2,054

-2,211

-2,325

-2,018

-1,911

-2,254

-853

-607

-1,530

OTHER INCOME (EXPENSE):
Grant income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

44

-

-

Loss on revaluation of derivative warrants

0

0

46

1

-4

43

66

-20

-26

5

9

90

-82

60

177

198

2,824

3,141

233

4

288

-1,083

2,850

573

-54

110

1,597

660

6

-

3

-17

-

-

-

-

-

-

-

Gain/(loss) on revaluation of derivative warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-28

-

3

-70

-

-

-

Loss on issuance of derivative warrants

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-744

0

0

0

0

-

-

-

-

-

-

Interest income, net

1

4

14

11

12

14

6

4

4

4

3

4

3

2

3

1

0

0

0

0

-1

-10

-253

-113

-69

-2

-2

-2

-2

-2

-2

-2

-2

-2

-1

-270

-156

-93

-91

Other income

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

-

0

0

-

-

-

Total other income, net

1

4

60

12

8

57

72

-15

-22

9

13

94

-79

63

181

200

2,825

2,737

234

4

286

-1,093

2,597

459

-124

107

1,595

658

-741

6

1

-19

-30

52

2

-340

-111

-93

-91

NET LOSS

-3,957

-3,379

-3,903

-3,187

-3,621

-3,827

-3,014

-2,920

-3,475

-4,078

-3,470

-3,121

-2,891

-2,585

-2,286

-2,132

824

950

-1,858

-2,286

-2,301

-3,346

324

-2,085

-2,943

-3,948

-1,315

-2,064

-3,453

-2,157

-2,052

-2,230

-2,356

-1,965

-1,909

-2,595

-965

-700

-1,621

DEEMED DIVIDEND ON PREFERRED STOCK

-

-

-

-

-

-

2,241

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

DEEMED DIVIDEND ON WARRANTS

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-543

0

0

-

-

-

-

-

-

DEEMED DIVIDEND ON WARRANTS

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS

-

-

-3,903

-

-

-

-5,256

-

-

-

-3,470

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3,453

-2,157

-2,595

-2,230

-2,356

-

-1,909

-

-

-

-

BASIC AND DILUTED NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS PER COMMON SHARE

-0.42

-0.20

-0.42

-0.46

-0.76

0.18

-1.65

-1.69

-2.07

-5.56

-2.58

-2.32

-0.24

-2.18

-0.43

-0.49

0.96

-

-2.46

-3.02

-

-15.83

0.06

-0.73

-1.03

-2.61

-0.46

-0.72

-0.07

-0.05

-0.06

-0.06

-0.06

-0.06

-0.07

-0.10

-0.08

-0.05

-0.13

SHARES USED IN COMPUTING BASIC AND DILUTED NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS PER COMMON SHARE

9,389

9,576

9,386

6,963

4,773

5,250

3,184

1,731

1,680

-9,091

1,347

1,346

12,010

6,911

5,368

4,328

858

-

756

756

-

-8,914

5,012

2,869

2,869

-45,848

2,869

2,869

51,286

45,689

43,286

38,598

36,910

-

26,826

25,743

-

-

-

BASIC NET INCOME (LOSS) PER COMMON SHARE

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-3.04

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

SHARES USED IN COMPUTING BASIC NET INCOME (LOSS) PER COMMON SHARE

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

756

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

DILUTED NET INCOME (LOSS) PER COMMON SHARE

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.91

-

-

-

-3.04

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

SHARES USED IN COMPUTING DILUTED NET INCOME (LOSS) PER COMMON SHARE

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

906

-

-

-

756

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

SHARES USED IN COMPUTING BASIC AND DILUTED NET LOSS PER COMMON SHARE

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

12,820

12,820

12,820